Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 143.8B | 143.3B | 140.2B | 130.8B |
Cost of revenue | 100.7B | 102.0B | 99.0B | 97.1B |
Gross profit | 43.0B | 41.3B | 41.2B | 33.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 17.9B | 17.9B | 17.5B | 9.1B |
Non operating interest income | ||||
Income | 463M | 421M | 396M | 285M |
Expense | 408M | 426M | 414M | 418M |
Other income expense | — | — | — | — |
Pretax income | 17.2B | 18.7B | 19.6B | 20.4B |
Tax provision | 5.3B | 4.0B | 4.8B | 5.4B |
Net income | 11.9B | 14.8B | 14.9B | 15.0B |
Basic EPS | — | — | — | 52.5 |
Diluted EPS | — | — | — | 52.5 |
Basic average shares | — | — | — | 285.6M |
Diluted average shares | — | — | — | 285.6M |
EBITDA | 20.6B | 17.9B | 18.4B | 13.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -297M | -302M | -106M | -5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |